All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
GOLSEEK-2 - Golcadomide plus Rituximab for Follicular Lymphoma
A Study to Assess the Efficacy and Safety of Golcadomide and Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma
HyNOVA - Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer
This study is investigating the safety of administering heated (42 degrees Celsius) versus normal temperature (37 degrees Celsius) chemotherapy during surgery for ovarian cancer patients.
INX-315-01
This study will investigate the use of a new medicine called INX-315 which may be used in the future as a possible treatment for advanced solid tumours.
IOS-1002-201 - administered alone and in combination with a PD-1 monoclonal antibody in advanced solid tumors
A Phase 1a/1b, first-in-human, open-label, non-randomized, multicenter, dose-escalation and cohort expansion study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics, and pharmacodynamics of IOS-1002 administered alone and in combination with a PD-1 monoclonal antibody in advanced solid tumors.
iSEARCH - Improving outcomes for women and babies by increasing placental blood flow to reduce fetal distress during labour
JetPlane CPAP (Continuous Positive Air Pressure) Interface & Accessories Product Evaluation Study – CIA-235
Keynote-B15
The trial is testing a potential new treatment for Muscle-invasive Bladder Cancer.
lidERA - Trialing a new oral hormone receptor blocker in estrogen receptor positive breast cancer
Evaluating the efficacy and safety of post surgical Giredestrant compared with doctors choice of endocrine therapy (Tamoxifen, Anastrozole, Letrozole or Exemestane) in patients with estrogen receptor−positive, HER2-negative early breast cancer.
Light Knee Study - A randomized control trial examining photobiomodulation (PBM) therapy before and after knee replacement surgery.
Evaluating the efficacy and safety of post surgical Giredestrant compared with doctors choice of endocrine therapy (Tamoxifen, Anastrozole, Letrozole or Exemestane) in patients with estrogen receptor−positive, HER2-negative early breast cancer.
Lung ultrasound to direct chest physiotherapy in neonates
In neonates, how effective is lung ultrasonography in directing the use of CPT intervention when compared to the combination of CXR and auscultation?